Table 5.

Results of cost-effectiveness analysis of different high-risk group TB screening.

Strategy	Cost per screening (MYR)	TB cases detected (per 1,000 screening)	Cost per TB case detected (MYR)	ICER
CCRC inmates	40.83	3.2	12,809.08	-	Dominant*
Elderly nursing home residents	40.95	0.0	na	−38.54	Dominated**
ESRF	41.01	4.3	9,456.83	154.02	Ext. Dominated***
Prisoner	41.20	13.4	3,065.24	21.23	Dominant*
Diabetes mellitus	41.50	3.1	13,214.26	−28.94	Dominated**
Methadone clinic client	41.63	0.0	na	−32.42	Dominated**
Rheumatoid arthritis	43.34	0.0	na	−159.41	Dominated**
PL HIV	43.69	16.8	2,597.00	735.82	Dominant*
COAD	43.76	5.8	7,590.33	−6.81	Dominated**
Smoker	43.87	10.1	4,327.76	−27.44	Dominated**
Elderly (60 years and above)	44.85	15.6	2,868.62	−979.43	Dominated**

ICER, incremental cost-effectiveness ratio.

^*Better outcomes, lower costs.

^**Worse outcomes, higher costs.

^***Better outcomes, lower costs but the subsequent strategy has a positive ICER.